Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OSI Systems | OSIS | May 16, 2024 | 137.42 | -1.81 |
Osiris Acquisition A | OSI | May 16, 2024 | 10.65 | +0.28 |
Osisko Development | ODV | May 16, 2024 | 2.23 | -0.45 |
Osisko Gold Royalties | OR | May 16, 2024 | 16.30 | -0.85 |
Ostin Technology Group | OST | May 16, 2024 | 0.42 | +4.00 |
Otis Worldwide | OTIS | May 16, 2024 | 96.56 | -0.73 |
Otter Tail | OTTR | May 16, 2024 | 92.22 | +0.23 |
Ouster | OUST | May 16, 2024 | 11.66 | -3.64 |
Outfront Media | OUT | May 16, 2024 | 15.06 | -1.63 |
Outlook Therapeutics | OTLK | May 16, 2024 | 7.33 | -1.35 |
Outset Medical | OM | May 16, 2024 | 3.52 | -1.12 |
Overseas Shipholding A | OSG | May 16, 2024 | 6.70 | -2.76 |
Ovid Therapeutics | OVID | May 16, 2024 | 3.27 | -1.36 |
Ovintiv | OVV | May 16, 2024 | 49.30 | -1.36 |
Owens & Minor | OMI | May 16, 2024 | 19.11 | -5.44 |
Owens Corning | OC | May 16, 2024 | 173.72 | -3.20 |
Owlet A | OWLT | May 16, 2024 | 3.99 | +4.18 |
Oxbridge Re | OXBR | May 16, 2024 | 1.75 | +10.76 |
Oxford Industries | OXM | May 16, 2024 | 107.33 | +0.71 |
Oxford Lane Capital | OXLC | May 16, 2024 | 5.39 | -0.74 |
Oxford Lane Capital 2024 Pref | OXLCM | May 16, 2024 | 24.94 | -0.56 |
Oxford Lane Capital 2027 Pref | OXLCP | May 16, 2024 | 23.72 | +0.09 |
Oxford Square Capital | OXSQ | May 16, 2024 | 3.16 | -1.86 |
P.A.M. Transportation Services | PTSI | May 16, 2024 | 17.67 | +0.97 |
P10 | PX | May 16, 2024 | 8.29 | +0.12 |
P3 Health Partners A | PIII | May 16, 2024 | 0.60 | -2.33 |
PACCAR | PCAR | May 16, 2024 | 105.93 | -1.99 |
Pacific Biosciences of California | PACB | May 16, 2024 | 2.19 | +2.10 |
Pacific ETF FTSE Vanguard | VPL | May 16, 2024 | 74.86 | -0.65 |
Pacific Ex-Japan MSCI Ishares | EPP | May 16, 2024 | 44.94 | +0.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.